Evoq Remedies Limited (BOM:543500)
2.670
-0.270 (-9.18%)
At close: Mar 9, 2026
Evoq Remedies Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2019 |
| Cash & Equivalents | 3.08 | 2.14 | 1.23 | 1.54 | 30.94 | 0.33 | Upgrade
|
| Cash & Short-Term Investments | 3.08 | 2.14 | 1.23 | 1.54 | 30.94 | 0.33 | Upgrade
|
| Cash Growth | 18.89% | 73.50% | -19.66% | -95.04% | 9179.27% | 1415.67% | Upgrade
|
| Accounts Receivable | 43.9 | 86.17 | 17.43 | 172.16 | 253.98 | 68.36 | Upgrade
|
| Receivables | 370.45 | 365.28 | 332.78 | 250.85 | 291.33 | 77.06 | Upgrade
|
| Inventory | 19.88 | 22.19 | 31.25 | 20.32 | 7.84 | 1.51 | Upgrade
|
| Other Current Assets | 126.77 | 108.25 | 3.21 | 76.19 | 3.2 | 1.56 | Upgrade
|
| Total Current Assets | 520.18 | 497.86 | 368.47 | 348.89 | 333.31 | 80.46 | Upgrade
|
| Property, Plant & Equipment | 1.97 | 2.23 | 0.14 | 0.09 | - | - | Upgrade
|
| Other Long-Term Assets | - | - | - | 0 | - | - | Upgrade
|
| Total Assets | 522.15 | 500.09 | 368.61 | 348.99 | 333.31 | 80.46 | Upgrade
|
| Accounts Payable | 7.59 | 34.97 | 32.83 | -5.37 | 12.09 | 67.83 | Upgrade
|
| Accrued Expenses | 7.52 | 3.2 | 0.1 | 0.12 | 4.31 | 2.02 | Upgrade
|
| Short-Term Debt | - | - | 42.38 | 95.76 | 81.58 | - | Upgrade
|
| Current Income Taxes Payable | - | 7.2 | 8.14 | 8.67 | 3.67 | 2.38 | Upgrade
|
| Other Current Liabilities | 61.13 | 9.37 | 32.78 | 1.95 | - | 0.79 | Upgrade
|
| Total Current Liabilities | 76.25 | 54.73 | 116.23 | 101.13 | 101.65 | 73.02 | Upgrade
|
| Long-Term Debt | - | - | - | - | - | 0.01 | Upgrade
|
| Total Liabilities | 76.25 | 54.73 | 116.23 | 101.13 | 101.65 | 73.03 | Upgrade
|
| Common Stock | 249 | 249 | 136 | 136 | 136 | 0.1 | Upgrade
|
| Additional Paid-In Capital | - | 163.52 | 84.42 | 84.42 | 84.42 | - | Upgrade
|
| Retained Earnings | - | 32.84 | 31.96 | 27.44 | 11.24 | 7.33 | Upgrade
|
| Shareholders' Equity | 445.9 | 445.36 | 252.38 | 247.86 | 231.66 | 7.43 | Upgrade
|
| Total Liabilities & Equity | 522.15 | 500.09 | 368.61 | 348.99 | 333.31 | 80.46 | Upgrade
|
| Total Debt | - | - | 42.38 | 95.76 | 81.58 | 0.01 | Upgrade
|
| Net Cash (Debt) | 3.08 | 2.14 | -41.15 | -94.23 | -50.64 | 0.32 | Upgrade
|
| Net Cash Per Share | 0.12 | 0.09 | -3.03 | -6.93 | -5.06 | 0.32 | Upgrade
|
| Filing Date Shares Outstanding | 27.15 | 24.9 | 13.6 | 13.6 | 13.6 | 0.71 | Upgrade
|
| Total Common Shares Outstanding | 27.15 | 24.9 | 13.6 | 13.6 | 13.6 | 0.71 | Upgrade
|
| Working Capital | 443.94 | 443.13 | 252.24 | 247.76 | 231.66 | 7.44 | Upgrade
|
| Book Value Per Share | 16.42 | 17.89 | 18.56 | 18.22 | 17.03 | 10.47 | Upgrade
|
| Tangible Book Value | 445.9 | 445.36 | 252.38 | 247.86 | 231.66 | 7.43 | Upgrade
|
| Tangible Book Value Per Share | 16.42 | 17.89 | 18.56 | 18.22 | 17.03 | 10.47 | Upgrade
|
| Machinery | - | - | - | 0.13 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.